Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
Abstract:
Provided herein are methods for identifying new biomarkers for various diseases using proteomics, peptidomics, metabolics, proteoglycomics, glycomics, mass spectrometry and machine learning. The present disclosure also provides glycopeptides as biomarkers for various diseases such as cancer and autoimmune diseases.
Information query
Patent Agency Ranking
0/0